Heba Abdel‐Halim

598 total citations
21 papers, 402 citations indexed

About

Heba Abdel‐Halim is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Heba Abdel‐Halim has authored 21 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Heba Abdel‐Halim's work include Analytical Chemistry and Chromatography (3 papers), Computational Drug Discovery Methods (2 papers) and Insect and Pesticide Research (2 papers). Heba Abdel‐Halim is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Computational Drug Discovery Methods (2 papers) and Insect and Pesticide Research (2 papers). Heba Abdel‐Halim collaborates with scholars based in Jordan, Australia and Saudi Arabia. Heba Abdel‐Halim's co-authors include Jane R. Hanrahan, Abeer Abdelhalim, Nasiara Karim, Nausheen Nazir, Graham A.R. Johnston, Mary Chebib, David E. Hibbs, Talal Aburjaı, Imran Khan and Mohammad Nisar and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Applied Microbiology and Biotechnology.

In The Last Decade

Heba Abdel‐Halim

21 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba Abdel‐Halim Jordan 11 163 58 57 57 44 21 402
Fernanda Majolo Brazil 13 234 1.4× 43 0.7× 104 1.8× 36 0.6× 31 0.7× 32 559
Jianming Cheng China 9 193 1.2× 36 0.6× 45 0.8× 60 1.1× 24 0.5× 49 377
Beatrice Gorelli Italy 11 170 1.0× 85 1.5× 45 0.8× 23 0.4× 63 1.4× 21 406
Nahid Rahbar‐Roshandel Iran 9 220 1.3× 34 0.6× 106 1.9× 23 0.4× 34 0.8× 14 412
Johann Sohn United States 13 218 1.3× 32 0.6× 30 0.5× 47 0.8× 33 0.8× 28 472
Neeraj Tiwari India 11 181 1.1× 69 1.2× 32 0.6× 75 1.3× 24 0.5× 23 570
Yue Dai China 16 284 1.7× 37 0.6× 74 1.3× 86 1.5× 31 0.7× 27 582
Solomon Kweku Sagoe Amoah Brazil 9 134 0.8× 22 0.4× 108 1.9× 56 1.0× 68 1.5× 18 426
Michelli Erica Souza Ferreira Brazil 5 130 0.8× 33 0.6× 48 0.8× 40 0.7× 27 0.6× 10 481
Shikha Lohan India 10 126 0.8× 32 0.6× 26 0.5× 92 1.6× 18 0.4× 12 662

Countries citing papers authored by Heba Abdel‐Halim

Since Specialization
Citations

This map shows the geographic impact of Heba Abdel‐Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Abdel‐Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Abdel‐Halim more than expected).

Fields of papers citing papers by Heba Abdel‐Halim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba Abdel‐Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Abdel‐Halim. The network helps show where Heba Abdel‐Halim may publish in the future.

Co-authorship network of co-authors of Heba Abdel‐Halim

This figure shows the co-authorship network connecting the top 25 collaborators of Heba Abdel‐Halim. A scholar is included among the top collaborators of Heba Abdel‐Halim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba Abdel‐Halim. Heba Abdel‐Halim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abdel‐Halim, Heba, et al.. (2022). Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach. Drug Design Development and Therapy. Volume 16. 2995–3013. 8 indexed citations
3.
Hamdan, Imad I., et al.. (2022). Interaction of esomeprazole with insulin detemir and human albumin: A potential cause of hypoglycemia. Biophysical Chemistry. 285. 106809–106809. 4 indexed citations
4.
Al‐Shdefat, Ramadan, Mohammad Hailat, Mohamed J. Saadh, et al.. (2021). Evidence of human metabolites of omeprazole and its structure elucidation by using HPLC-MS. Journal of Molecular Structure. 1230. 129902–129902. 5 indexed citations
5.
Abdel‐Halim, Heba. (2020). The Effectiveness of Using Three-Dimensional Visualization Tools to Improve Students’ Understanding of Medicinal Chemistry and Advanced Drug Design Concepts. International Journal of Learning Teaching and Educational Research. 19(4). 170–187. 3 indexed citations
7.
Abdel‐Halim, Heba, et al.. (2019). The search of potential inhibitors of the AcrAB–TolC system of multidrug-resistant Escherichia coli: an in silico approach. Applied Microbiology and Biotechnology. 103(15). 6309–6318. 27 indexed citations
8.
Nazir, Nausheen, Muhammad Zahoor, Mohammad Nisar, et al.. (2018). Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach. BMC Complementary and Alternative Medicine. 18(1). 332–332. 63 indexed citations
9.
Abdelhalim, Abeer, Talal Aburjaı, Jane R. Hanrahan, & Heba Abdel‐Halim. (2017). Medicinal plants used by traditional healers in Jordan, the Tafila region. Pharmacognosy Magazine. 13(49). 95–95. 48 indexed citations
10.
Sunoqrot, Suhair, Rania Hamed, Heba Abdel‐Halim, & Ola Tarawneh. (2017). Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology – From Drug Discovery to Nanocarrier Design and Development. Current Topics in Medicinal Chemistry. 17(13). 1451–1468. 14 indexed citations
11.
Karim, Nasiara, Imran Khan, Abeer Abdelhalim, Heba Abdel‐Halim, & Jane R. Hanrahan. (2017). Molecular docking and antiamnesic effects of nepitrin isolated from Rosmarinus officinalis on scopolamine-induced memory impairment in mice. Biomedicine & Pharmacotherapy. 96. 700–709. 24 indexed citations
13.
Sweidan, Kamal, Dima A. Sabbah, Jörn Engelmann, Heba Abdel‐Halim, & Ghassan Abu Sheikha. (2015). Computational Docking Studies of Novel Heterocyclic Carboxamides as Potential PI3Kα Inhibitors. Letters in Drug Design & Discovery. 12(10). 856–863. 11 indexed citations
14.
Failes, Timothy W., Heba Abdel‐Halim, Sela T. Po’uha, et al.. (2012). Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells. PLoS ONE. 7(2). e30734–e30734. 19 indexed citations
15.
Xie, An, Jun Yan, Yue Lan, et al.. (2011). 2-Aminoethyl Methylphosphonate, a Potent and Rapidly Acting Antagonist of GABAA-ρ1 Receptors. Molecular Pharmacology. 80(6). 965–978. 5 indexed citations
16.
Abdel‐Halim, Heba, Daniela Traini, David E. Hibbs, Simon Gaisford, & Paul M. Young. (2010). Modelling of molecular phase transitions in pharmaceutical inhalation compounds: An in silico approach. European Journal of Pharmaceutics and Biopharmaceutics. 78(1). 83–89. 17 indexed citations
17.
Failes, Timothy W., Heba Abdel‐Halim, Marjorie Liu, et al.. (2009). Abstract A156: Mechanisms of resistance to Aurora kinase B inhibitors in leukemia: Development and characterization of in vitro models. Molecular Cancer Therapeutics. 8(12_Supplement). A156–A156. 1 indexed citations
18.
Chebib, Mary, Tina Hinton, Katrina L. Schmid, et al.. (2008). Novel, Potent, and Selective GABAC Antagonists Inhibit Myopia Development and Facilitate Learning and Memory. Journal of Pharmacology and Experimental Therapeutics. 328(2). 448–457. 64 indexed citations
19.
Abdel‐Halim, Heba, Jane R. Hanrahan, David E. Hibbs, Graham A.R. Johnston, & Mary Chebib. (2008). A Molecular Basis for Agonist and Antagonist Actions at GABAC Receptors. Chemical Biology & Drug Design. 71(4). 306–327. 41 indexed citations
20.
Taha, Mutasem O., Heba Abdel‐Halim, Mutasim Al-Ghazawi, & Enam A. Khalil. (2005). QSPR modeling of pseudoternary microemulsions formulated employing lecithin surfactants: Application of data mining, molecular and statistical modeling. International Journal of Pharmaceutics. 295(1-2). 135–155. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026